PortfoliosLab logoPortfoliosLab logo
XHE vs. IDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XHE vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Health Care Equipment ETF (XHE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XHE achieves a -8.91% return, which is significantly lower than IDNA's 17.72% return.


XHE

1D
-2.39%
1M
-0.92%
YTD
-8.91%
6M
-10.99%
1Y
1.37%
3Y*
-5.83%
5Y*
-8.97%
10Y*
6.02%

IDNA

1D
0.46%
1M
4.69%
YTD
17.72%
6M
14.99%
1Y
51.77%
3Y*
10.60%
5Y*
-8.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

XHE vs. IDNA - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
XHE
SPDR S&P Health Care Equipment ETF
-8.91%-0.23%5.08%-6.23%-23.34%3.04%32.91%7.82%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
17.72%17.26%-0.72%-7.63%-42.28%-3.98%54.30%22.10%

Correlation

The correlation between XHE and IDNA is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.54

Correlation (3Y)
Calculated over the trailing 3-year period

0.60

Correlation (5Y)
Calculated over the trailing 5-year period

0.68

Correlation (All Time)
Calculated using the full available price history since Jun 13, 2019

0.69

The correlation between XHE and IDNA shifts across timeframes, from 0.54 (1 year) to 0.69 (all time), reflecting how their relationship changes across market environments.

XHE vs. IDNA - Sectors Allocation Comparison


Sectors
XHE
IDNA

Healthcare

98.2%
99.3%

Financial Services

1.8%

-

Industrials

1.7%
0.3%

Communication Services

1.4%

-

Basic Materials

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XHE
98.2%
IDNA
99.3%

Financial Services

XHE
1.8%
IDNA

-

Industrials

XHE
1.7%
IDNA
0.3%

Communication Services

XHE
1.4%
IDNA

-

Basic Materials

XHE

-

IDNA

-

Consumer Cyclical

XHE

-

IDNA

-

Consumer Defensive

XHE

-

IDNA

-

Energy

XHE

-

IDNA

-

Real Estate

XHE

-

IDNA

-

Technology

XHE

-

IDNA

-

Utilities

XHE

-

IDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XHE vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XHE
XHE Risk / Return Rank: 99
Overall Rank
XHE Sharpe Ratio Rank: 99
Sharpe Ratio Rank
XHE Sortino Ratio Rank: 99
Sortino Ratio Rank
XHE Omega Ratio Rank: 99
Omega Ratio Rank
XHE Calmar Ratio Rank: 99
Calmar Ratio Rank
XHE Martin Ratio Rank: 99
Martin Ratio Rank

IDNA
IDNA Risk / Return Rank: 7070
Overall Rank
IDNA Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 6666
Sortino Ratio Rank
IDNA Omega Ratio Rank: 5555
Omega Ratio Rank
IDNA Calmar Ratio Rank: 8888
Calmar Ratio Rank
IDNA Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XHE vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Equipment ETF (XHE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XHEIDNADifference
Sharpe ratioReturn per unit of total volatility

-2.03

Sortino ratioReturn per unit of downside risk

-2.66

Omega ratioGain probability vs. loss probability

1.03

1.33

-0.30

Calmar ratioReturn relative to maximum drawdown

0.08

4.88

-4.80

Martin ratioReturn relative to average drawdown

0.16

13.60

-13.44

XHE vs. IDNA - Sharpe Ratio Comparison

The current XHE Sharpe Ratio is 0.06, which is lower than the IDNA Sharpe Ratio of 2.09. The chart below compares the historical Sharpe Ratios of XHE and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XHE vs. IDNA - Drawdown Comparison

The maximum XHE drawdown since its inception was -49.92%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for XHE and IDNA.


Loading charts...

Drawdown Indicators


XHEIDNADifference

Max Drawdown

Largest peak-to-trough decline

-49.92%

-68.26%

+18.34%

Max Drawdown (1Y)

Largest decline over 1 year

-18.29%

-10.66%

-7.63%

Max Drawdown (3Y)

Largest decline over 3 years

-32.62%

-29.46%

-3.16%

Max Drawdown (5Y)

Largest decline over 5 years

-49.92%

-68.26%

+18.34%

Max Drawdown (10Y)

Largest decline over 10 years

-49.92%

Current Drawdown

Current decline from peak

-39.61%

-41.96%

+2.35%

Average Drawdown

Average peak-to-trough decline

-13.34%

-36.28%

+22.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.42%

3.82%

+4.60%

Volatility

XHE vs. IDNA - Volatility Comparison

SPDR S&P Health Care Equipment ETF (XHE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.40% and 7.25%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XHEIDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.40%

7.25%

+0.15%

Volatility (6M)

Calculated over the trailing 6-month period

16.50%

18.40%

-1.90%

Volatility (1Y)

Calculated over the trailing 1-year period

22.12%

24.97%

-2.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.56%

28.46%

-3.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.00%

29.52%

-6.52%

XHE vs. IDNA - Expense Ratio Comparison

XHE has a 0.35% expense ratio, which is lower than IDNA's 0.47% expense ratio.


Dividends

XHE vs. IDNA - Dividend Comparison

XHE's dividend yield for the trailing twelve months is around 0.09%, less than IDNA's 0.91% yield.


PositionTTM20252024202320222021202020192018201720162015
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
0.91%1.18%0.98%1.04%0.54%0.70%0.26%0.80%0.00%0.00%0.00%0.00%
XHE
SPDR S&P Health Care Equipment ETF
0.06%0.08%0.04%0.03%0.04%0.00%0.00%0.05%0.09%0.78%0.17%7.22%

Frequently Asked Questions


XHE and IDNA have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XHE has higher volatility (7.40%) compared to IDNA (7.25%). In terms of maximum drawdown, XHE dropped -49.92% vs IDNA's -68.26%.

On 5-year performance, IDNA leads with -8.07% vs -8.97% for XHE. On fees, XHE is cheaper at 0.35% per year. On volatility, IDNA has been the lower-risk option at 7.25%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IDNA has performed better with a -8.07% return vs -8.97%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XHE is cheaper with a 0.35% expense ratio, compared with 0.47% for IDNA.

IDNA has the higher dividend yield at 0.91%, compared with 0.09% for XHE.

XHE tracks S&P Health Care Equipment Select Industry Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: State Street and iShares. Their fees differ too: 0.35% for XHE and 0.47% for IDNA.

IDNA currently has the higher Sharpe Ratio (2.09 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XHE and IDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer